LloydsPharmacy Clinical Homecare awarded overall ‘Good’ rating by CQC


Share post:

LloydsPharmacy Clinical Homecare has been awarded ‘Good’ rating in all five domains- safe, effective, caring, responsive and well-led by the Care Quality Commission (CQC).

This is recognition of the huge turnaround the service has made in such a short space of time. The Harlow site was inspected in October 2022.

Established in 1975, LloydsPharmacy Clinical Homecare is one of the most experienced providers of clinical homecare, and delivers care to more than 100,000 patients in the comfort of their home, at work, or in the community – ranging from straightforward delivery of medication to specialist nursing for complex conditions. The provider was credited with having ‘significantly improved’ following negative feedback from the regulators last year.

In particular, it was reported that ‘all staff were committed to continually learning and improving services. They had a good understanding of quality improvement methods and the skills to use them, and leaders encouraged innovation and participation in research’.

Inspectors highlighted LloydsPharmacy Clinical Homecare’s Remote Nurse Training service, which is for patients with long-term conditions. ‘The service has enabled patients, through telephone training, to self-inject their ongoing treatments. It has facilitated greater independence for patients and has reduced the risk of transmission of the COVID-19 virus to a patient group that were considered vulnerable.’

With a success rate of 99%, the training programme was rolled out nationally across 13 different biological therapies. The service was a finalist in the Nursing Times Awards 2020 in the category of Managing Long-term Conditions.

Nick Davis, CEO of LloydsPharmacy Clinical Homecare, said: “The CQC’s report reflects how far we have come in the last year. Every single person who is part of the LloydsPharmacy Clinical Homecare team – from our front-line nurses and healthcare assistants to our senior management team, has worked extremely hard to bring the service back to a standard that we can be proud of, however, we will not rest on our laurels as we strive to do even better each day.

“We are all dedicated to our programme of continuous improvement, and the regulator’s feedback is extremely important to us. The inspectors have also provided valuable guidance on where we can make even more progress, and it will help us reach our goal of being rated outstanding in the near future.”




Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...